Waverton Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$53.3M |
| 2 |
CME Group
CME
|
+$39.7M |
| 3 |
Synopsys
SNPS
|
+$37.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.2M |
| 5 |
Microsoft
MSFT
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$35M |
| 2 |
HCA Healthcare
HCA
|
+$16.2M |
| 3 |
GE Aerospace
GE
|
+$11.5M |
| 4 |
T-Mobile US
TMUS
|
+$8.42M |
| 5 |
Texas Pacific Land
TPL
|
+$8.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.05% |
| 2 | Financials | 19.62% |
| 3 | Industrials | 11.51% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Healthcare | 10.27% |
Similar funds
Waverton Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, Waverton Investment Management held 106 positions worth $6.28B, up 3.1% from $6.09B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Waverton Investment Management deployed $279M of net new capital in Q4 2024, opening 8 new positions and adding to 41 existing holdings. Its largest new stake was GE HealthCare: 626,507 shares worth $49M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was GE Vernova, an estimated $35M trimmed.
- Waverton Investment Management's largest Q4 2024 buy was GE HealthCare: 626,507 shares worth $49M.
- Waverton Investment Management added most to CME Group in Q4 2024, an estimated $39.7M increase.
- Waverton Investment Management's biggest Q4 2024 reduction was GE Vernova, cutting an estimated $35M.
- Waverton Investment Management fully exited Pinterest in Q4 2024, selling an estimated $4.71M.
- Waverton Investment Management's ten largest holdings make up 46% of its $6.28B portfolio in Q4 2024.
- Waverton Investment Management opened 8 new positions and closed 5 in Q4 2024.
- Waverton Investment Management's portfolio value rose 3.1% quarter-over-quarter to $6.28B.
Based on Waverton Investment Management's 13F filing for Q4 2024, filed 4 Feb 2025.